Suchergebnisse - "Allegretti, Jessica R"

PubPharm (33)

1

Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era : A Narrative Review

enthalten in: Advances in therapy | 2024

von Allegretti, J. | Brady, J. | Wicker, A. | +2

2

Low-Dose Interleukin 2 for the Treatment of Moderate to Severe Ulcerative Colitis

enthalten in: Gastroenterology | 2023

von Allegretti, J. | Mitsialis, V. | Canavan, J. | +30

3

Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Vaughn, B. | Fischer, M. | Kelly, C. | +6

CommentIn: Clin Gastroenterol Hepatol. 2023 Aug;21(9):2432. - PMID 36307057

4

Long-Term Outcomes After Ustekinumab Dose Intensification for Inflammatory Bowel Diseases

enthalten in: Inflammatory bowel diseases | 2023

von Dalal, R. | Pruce, J. | Allegretti, J.

5

Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program

enthalten in: The patient | 2023

von Hudesman, D. | Torres, J. | Salese, L. | +5

6

Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naïve Patients with Ulcerative Colitis

enthalten in: Digestive diseases and sciences | 2023

von Dalal, R. | McClure, E. | Marcus, J. | +1

7

Assessing the clinical value of faecal bile acid profiling to predict recurrence in primary Clostridioides difficile infection

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Mullish, B. | Martinez-Gili, L. | Chekmeneva, E. | +10

CommentIn: Aliment Pharmacol Ther. 2023 Jan;57(1):167-168. - PMID 36468200

8

Tofacitinib for the Treatment of Pouch-Related Disorders : A Case Series

enthalten in: Inflammatory bowel diseases | 2022

von Dalal, R. | Bains, K. | Marcus, J. | +2

9

Predictors and Outcomes of Ustekinumab Dose Intensification in Ulcerative Colitis : A Multicenter Cohort Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Dalal, R. | Esckilsen, S. | Barnes, E. | +3

10

Gut metabolites predict Clostridioides difficile recurrence

enthalten in: Microbiome | 2022

von Dawkins, J. | Allegretti, J. | Gibson, T. | +4